• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur Heart J. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019

tetano

Editor, Senior Moderator
Eur Heart J. 2020 May 11. pii: ehaa408. doi: 10.1093/eurheartj/ehaa408. [Epub ahead of print]
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019.


Shi S[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Qin M[SUP]4[/SUP], Cai Y[SUP]5[/SUP], Liu T[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Shen B[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Yang F[SUP]6[/SUP], Cao S[SUP]7[/SUP], Liu X[SUP]4[/SUP], Xiang Y[SUP]8[/SUP], Zhao Q[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Huang H[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Yang B[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Huang C[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP].

Author information




Abstract

AIMS:

To investigate the characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019 (COVID-19).
METHODS AND RESULTS:

We enrolled 671 eligible hospitalized patients with severe COVID-19 from 1 January to 23 February 2020, with a median age of 63 years. Clinical, laboratory, and treatment data were collected and compared between patients who died and survivors. Risk factors of death and myocardial injury were analysed using multivariable regression models. A total of 62 patients (9.2%) died, who more often had myocardial injury (75.8% vs. 9.7%; P < 0.001) than survivors. The area under the receiver operating characteristic curve of initial cardiac troponin I (cTnI) for predicting in-hospital mortality was 0.92 [95% confidence interval (CI), 0.87-0.96; sensitivity, 0.86; specificity, 0.86; P < 0.001]. The single cut-off point and high level of cTnI predicted risk of in-hospital death, hazard ratio (HR) was 4.56 (95% CI, 1.28-16.28; P = 0.019) and 1.25 (95% CI, 1.07-1.46; P = 0.004), respectively. In multivariable logistic regression, senior age, comorbidities (e.g. hypertension, coronary heart disease, chronic renal failure, and chronic obstructive pulmonary disease), and high level of C-reactive protein were predictors of myocardial injury.
CONCLUSION:

The risk of in-hospital death among patients with severe COVID-19 can be predicted by markers of myocardial injury, and was significantly associated with senior age, inflammatory response, and cardiovascular comorbidities.
Published on behalf of the European Society of Cardiology. All rights reserved. ? The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.



KEYWORDS:

Coronavirus disease 2019; Mortality; Myocardial injury; Risk


PMID:32391877DOI:10.1093/eurheartj/ehaa408
 
Back
Top Bottom